Search

Your search keyword '"Van Der Worp, H. Bart"' showing total 970 results

Search Constraints

Start Over You searched for: Author "Van Der Worp, H. Bart" Remove constraint Author: "Van Der Worp, H. Bart"
970 results on '"Van Der Worp, H. Bart"'

Search Results

4. Safety and efficacy of active blood-pressure reduction to the recommended thresholds for intravenous thrombolysis in patients with acute ischaemic stroke in the Netherlands (TRUTH): a prospective, observational, cluster-based, parallel-group study

5. Prevention of infections and fever to improve outcome in older patients with acute stroke (PRECIOUS): a randomised, open, phase III, multifactorial, clinical trial with blinded outcome assessment

6. Update on the INTEnsive ambulance-delivered blood pressure Reduction in hyper-ACute stroke Trial (INTERACT4): progress and baseline features in 2053 participants

8. Prediction of Outcome and Endovascular Treatment Benefit

9. Effects of oral anticoagulation in people with atrial fibrillation after spontaneous intracranial haemorrhage (COCROACH): prospective, individual participant data meta-analysis of randomised trials

10. Endovascular treatment versus no endovascular treatment after 6–24 h in patients with ischaemic stroke and collateral flow on CT angiography (MR CLEAN-LATE) in the Netherlands: a multicentre, open-label, blinded-endpoint, randomised, controlled, phase 3 trial

11. Prognostic Value of Thrombus Volume and Interaction With First-Line Endovascular Treatment Device Choice

13. Prehospital transdermal glyceryl trinitrate in patients with presumed acute stroke (MR ASAP): an ambulance-based, multicentre, randomised, open-label, blinded endpoint, phase 3 trial

15. Safety and efficacy of aspirin, unfractionated heparin, both, or neither during endovascular stroke treatment (MR CLEAN-MED): an open-label, multicentre, randomised controlled trial

16. Impact of the lockdown on acute stroke treatments during the first surge of the COVID-19 outbreak in the Netherlands

17. Apixaban versus no anticoagulation after anticoagulation-associated intracerebral haemorrhage in patients with atrial fibrillation in the Netherlands (APACHE-AF): a randomised, open-label, phase 2 trial

18. Endovascular treatment of patients with stroke caused by anterior cerebral artery occlusions

19. Prevention of infections and fever to improve outcome in older patients with acute stroke (PRECIOUS): a randomised, open, phase III, multifactorial, clinical trial with blinded outcome assessment

20. Intensive Ambulance-Delivered Blood-Pressure Reduction in Hyperacute Stroke

21. Prevalence and 3-month follow-up of cerebrovascular MRI markers in hospitalized COVID-19 patients: the CORONIS study

22. Safety and efficacy of active blood-pressure reduction to the recommended thresholds for intravenous thrombolysis in patients with acute ischaemic stroke in the Netherlands (TRUTH): a prospective, observational, cluster-based, parallel-group study

24. Improvements in Endovascular Treatment for Acute Ischemic Stroke: A Longitudinal Study in the MR CLEAN Registry

25. Medical management with interventional therapy versus medical management alone for unruptured brain arteriovenous malformations (ARUBA): final follow-up of a multicentre, non-blinded, randomised controlled trial

27. INTEnsive ambulance-delivered blood pressure Reduction in hyper-ACute stroke Trial (INTERACT4): study protocol for a randomized controlled trial

28. Stenting for symptomatic vertebral artery stenosis: a preplanned pooled individual patient data analysis

29. Risk, Clinical Course, and Outcome of Ischemic Stroke in Patients Hospitalized With COVID-19: A Multicenter Cohort Study

30. Effects of oral anticoagulation in people with atrial fibrillation after spontaneous intracranial haemorrhage (COCROACH): prospective, individual participant data meta-analysis of randomised trials

31. Association between thrombus composition and stroke etiology in the MR CLEAN Registry biobank

32. Restenosis and risk of stroke after stenting or endarterectomy for symptomatic carotid stenosis in the International Carotid Stenting Study (ICSS): secondary analysis of a randomised trial

35. Blood biomarker changes following therapeutic hypothermia in ischemic stroke

36. Workflow Intervals of Endovascular Acute Stroke Therapy During On- Versus Off-Hours: The MR CLEAN Registry

41. Collateral Circulation and Outcome in Atherosclerotic Versus Cardioembolic Cerebral Large Vessel Occlusion

42. Admission blood pressure and clinical outcomes in patients with acute ischaemic stroke treated with intravenous alteplase and endovascular treatment versus endovascular treatment alone: A MR CLEAN-NO IV substudy

43. Validity of Early Outcomes as Indicators for Comparing Hospitals on Quality of Stroke Care

44. Bifurcation occlusions and endovascular treatment outcome in acute ischemic stroke

45. Endovascular treatment for isolated posterior cerebral artery occlusion stroke in the MR CLEAN registry

46. Endovascular treatment versus no endovascular treatment after 6–24 h in patients with ischaemic stroke and collateral flow on CT angiography (MR CLEAN-LATE) in the Netherlands:a multicentre, open-label, blinded-endpoint, randomised, controlled, phase 3 trial

47. Assessment of aortic and cerebral haemodynamics and vascular brain injury with 3 and 7 T magnetic resonance imaging in patients with aortic coarctation

48. Antithrombotic Treatment in Patients With Hemophilia:an EHA-ISTH-EAHAD-ESO Clinical Practice Guidance

49. Bifurcation occlusions and endovascular treatment outcome in acute ischemic stroke

50. Cerebrospinal fluid volume improves prediction of malignant edema after endovascular treatment of stroke

Catalog

Books, media, physical & digital resources